502. Deputy Mairéad Farrell asked the Minister for Health if the approval of a drug will be expedited considering its urgent need by a person (details supplied). [31405/25]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
534. Deputy Conor Sheehan asked the Minister for Health if she will examine and expedite the approval of a new drug givinostat which has been approved in the UK and US for the treatment of Duchenne muscular dystrophy; and if she will make a statement on the matter. [31509/25]
542. Deputy Liam Quaide asked the Minister for Health her plans to expedite the national assessment and decision process for the use of duvyzat (givinostat) to treat patients with Duchenne muscular dystrophy; and if she will make a statement on the matter. [31557/25]
1352. Deputy Albert Dolan asked the Minister for Health the rationale for excluding evorel 100mcg patches from the new hormone replacement therapy (HRT) scheme, given its widespread use as a substitute for estradot, which has been in long-term short supply; the measures being taken to ensure continuity of HRT care for those impacted by the supply shortages of estradot, including the potential inclusion of alternative…
1380. Deputy Louis O'Hara asked the Minister for Health the reason evorel patches, which are being dispensed in place of estradot due to an ongoing shortage, are not covered under the new free hormone replacement therapy scheme; and if she will make a statement on the matter. [29459/25]
1381. Deputy Louis O'Hara asked the Minister for Health the steps being taken to ensure hormone replacement therapy (HRT) medicine alternatives such as evorel are included in the free HRT scheme, especially given the possible long-term unavailability of estradot; if her Department or the HSE plans to reassess the coverage of such alternative HRT medication under the free HRT scheme to ensure continuity of care; and i…
1450. Deputy David Cullinane asked the Minister for Health if she is aware of a shortage of a skin cancer drug efudix through pharmacies; the action being taken by her Department in relation to same; and if she will make a statement on the matter. [29703/25]
1467. Deputy Colm Burke asked the Minister for Health if she is concerned by the latest data from the EFPIA Patient Wait Indicator 2024, indicating an average wait time of 645 days for access to new medicines in Ireland, which constitutes a further disimprovement on last year's figures; to outline what plans are underway to improve the structures and speed of the system, in line with the Programme for Government comm…
1468. Deputy Colm Burke asked the Minister for Health if the 34 new whole-time equivalent positions for the agencies involved in the HSE's medicines pricing and reimbursement system, as initially prescribed in February 2023 by the then-Minister for Health, have now been successfully filled; whether they have commenced their engagement; and if she will make a statement on the matter. [29792/25]
1470. Deputy Colm Burke asked the Minister for Health her views on the findings of a report (details supplied) in relation to the development of a system of transferable exclusivity vouchers; whether she is supportive of the introduction of such a system at Irish and EU level; and if she will make a statement on the matter. [29794/25]
1479. Deputy Shane Moynihan asked the Minister for Health to outline the availability of estradot in Ireland, and if an alternative to this drug can be funded as part of the free HRT programme. [29831/25]
1481. Deputy Pádraig Rice asked the Minister for Health the reason for the delay in commencing the inquiry into the historical licensing and use of sodium valproate; the work carried out to date; the timeline for formal commencement; and if she will make a statement on the matter. [29835/25]
1511. Deputy Pádraig Rice asked the Minister for Health the number of patients receiving biologics medicines for severe asthma in 2024 and to date in 2025; and the specific biologic medicines included, in tabular form. [29978/25]
1512. Deputy Pádraig Rice asked the Minister for Health the number of patients receiving biologic medicines for severe asthma in 2024 and to date in 2025, by health region and hospital, in tabular form. [29979/25]
1513. Deputy Pádraig Rice asked the Minister for Health the status of the commissioned managed access protocol necessary for the reimbursement of a severe asthma biologic medicine for patients with EOS level greater than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29980/25]
1514. Deputy Pádraig Rice asked the Minister for Health the status of the health technology assessment ongoing with the National Centre for Pharmacoeconomics for a biologic medicine to be used for severe asthma patients with EOS level less than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29981/25]
1523. Deputy Barry Heneghan asked the Minister for Health if work has begun to explore early access schemes for certain medicines, as outlined in the Programme for Government; the person in her Department that will have responsibility for this work; if this will include a review of early access schemes already operating in other European countries; and if she will make a statement on the matter. [30015/25]
1551. Deputy Brian Stanley asked the Minister for Health further to Parliamentary Question No. 787 of 20 May 2025, around the reimbursement list scheme, the answer states that liraglutide (saxenda) is the only product currently approved under community drug schemes GMS/DPS for weight management, to clarify the criteria for use; if a person needs to be in diagnosis of prediabetes or can other factors such as high card…
1629. Deputy Claire Kerrane asked the Minister for Health when a drug (details supplied) will be available on the drugs payment scheme to ensure that for those unable to take any form of HRT, now free, can access the alternative for free; and if she will make a statement on the matter. [30656/25]
545. Deputy Noel McCarthy asked the Minister for Health to outline if VYLOY (zolbetuximab-clzb) is currently being reviewed for inclusion in the HSE reimbursement scheme; the status of such a review; and if she will make a statement on the matter. [28541/25]
646. Deputy David Cullinane asked the Minister for Health the estimated cost of reducing the drug payment scheme threshold in increments of €5 to €0, in tabular form. [28743/25]
674. Deputy Conor Sheehan asked the Minister for Health if weight-loss drugs such as ozempic and mounjaro will be made available to medical card patients; her views on whether they should; and if she will make a statement on the matter. [28848/25]
680. Deputy Pádraig Mac Lochlainn asked the Minister for Health if she will advise on a matter raised in correspondence (details supplied). [29078/25]
663. Deputy Brian Stanley asked the Minister for Health if combivent/pulmicort is covered under the GMS Scheme; if not, the reason for its removal; and if she will make a statement on the matter. [26941/25]
681. Deputy Ruth Coppinger asked the Minister for Health if she is aware of a shortage of Ipratropium Steri Neb (Ipramol), Salbutamol, and Atrovent; and if attempts have been made to address this, in light of the dangerous consequences for those reliant on this medication. [26993/25]